Microscopy & microtechniques
Easing the way for pain-free insulin injections
Mar 13 2006
Author: Matthew Williamson, Novo Nordisk and Chris Keeping on behalf of Novo Nordisk A/S
There are an estimated 194 million diabetics worldwide and at the present rate of growth, this figure will exceed 333 million by 2025 [1]. Since some 17 million of the 194 million suffer from Type 1 diabetes and rely on regular injections of insulin, there is continuous effort by manufacturers of insulin delivery devices and needles to minimise the pain associated with these vital injections. Materials testing methods have an important role in ensuring that needles and needle assemblies meet the needs for safe handling and easy, pain-free injection.
Digital Edition
ILM Guide 2025/26
June 2025
Buyers' Guide Listings- Product Listings by Category- Suppliers Listings (A-Z)Chromatography Articles- Setting the power coefficient and the baseline to linearise the signal of the evaporative ligh...
View all digital editions
Events
Jun 24 2025 Warsaw, Poland
Jun 24 2025 Shanghai, China
Discovery & Development Europe 2025
Jul 01 2025 Basel, Switzerland
Jul 01 2025 Manchester, UK
Jul 08 2025 Johannesburg, South Africa
